Australian-founded medical technology company SYMBYX today announced compelling results from a 72-week randomized controlled trial (RCT) demonstrating improvements in a range of Parkinson's disease ...
For more than 200 years, Parkinson’s disease has been treated as a one‑way street, with drugs and devices that ease symptoms but do not truly repair the brain. That assumption is now under direct ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results